-
1
β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer’s and Parkinson’s disease
Published 2025-02-01Subjects: Get full text
Article -
2
Exploring CJD incidence trends: insights from Slovakia
Published 2024-12-01Subjects: Get full text
Article